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Dear Editor, 
Malarial infection is not uncommonly complicated by 
cerebral involvement and poses signifi cant mortality and 
morbidity especially in children. Similar complications 
may be seen in the adult population. Cerebral malaria is 
defi ned as encephalopathy that presents with impaired 
consciousness, delirium, and/or seizures. Neurological 
defi cits are commonly seen as sequelae of cerebral malaria 
rather than as presenting symptoms or signs. 
We present here a unique case of cerebral malaria with 
focal neurological defi cits but without alteration in conscious 
level. Keeping rare presentations of common illnesses in 
mind, clinicians should consider the possibility of cerebral 
malaria in a patient with neurological defi cits and a history 
of fever and travel in endemic areas.
Case Presentation 
A 56-year-old gentleman presented to us with a 4-day 
history of fever and sudden onset of slurred speech with 
diffi culty in expressing himself on the day of presentation. 
Three weeks earlier, he had gone on a 5-day jungle 
exploration trip in northern Kedah without malaria 
prophylaxis. The fever was intermittent and was associated 
with chills and rigors. There was no loss of consciousness 
or altered behaviour. He had no past medical illness or 
history of prior hospitalisation. He did not have neurological 
symptoms prior to presentation or pre-existing neurological 
illness.  He was not on any over-the-counter medication 
nor did he consume traditional medicines.
On examination, the patient was febrile with expressive 
dysphasia and left cerebellar signs with dysmetria, and 
dysdiadochokinesia. Neurological examination was 
otherwise normal. Mini mental state examination could not 
be performed due to his expressive dysphasia. Systemic 
examination revealed no signifi cant fi ndings, such as 
irregular pulse, carotid bruit and cardiac murmur. Because 
of a high clinical suspicion, a peripheral blood fi lm was 
requested and this confi rmed the presence of Plasmodium 
falciparum with a parasite count of 6634 parasites per 
milliliter of blood. 
Initial investigations revealed that he had normochromic 
normocytic anaemia with haemoglobin 8.8 g/dL, leukocyte 
count 5.6 x 109/L and platelet count 266 x 109/L. There 
was also renal impairment with urea of 21.2 mmol/L and 
creatinine 174 umol/L, which was later corrected with 
hydration. Corrected calcium was 2.3 mmol/L. Coagulation 
profi le showed PT 11.5s, aPTT 21.0s and INR of 1.1. 
Bilirubin and alanine transaminase were 19 umol/L and 63 
U/L respectively. The random blood sugar was 6.0 mmol/L. 
The cerebrospinal fl uid analysis revealed a normal cell count, 
protein level of 250 mg/L and a glucose level of 4.4 mmol/L. 
The cerebrospinal fl uid was negative for herpes simplex 
viral polymerase chain reaction, cryptococcal antigen, and 
Indian ink. The blood, urine and cerebrospinal fl uid cultures 
were also negative. Computed tomography and magnetic 
resonance imaging of the brain were normal. Autoimmune 
studies and leptospira serology were not performed. There 
were no dyslipidaemia or dysglycaemia. Echocardiogram 
was normal. 
The patient was given intravenous quinine, which was 
subsequently changed to quinine and doxycycline oral 
therapy. With the initiation of therapy, the dysphasia, 
dysmetria, and dysdiadochokinesia, improved gradually. 
On day 10 of presentation, blood fi lm revealed no more 
malaria parasites. Upon discharge on day 13, there was 
some residual expressive dysphasia, but no dysmetria and 
dysdiadochokinesia. When the patient returned again to the 
outpatient clinic a month later, he had made a full recovery 
with normal speech and cerebellar function.  
Discussion
The presentation of the patient is unique in that no coma 
was observed. Instead, focal neurological signs were the 
presenting complaint, and recovery was achieved with 
anti-malarial therapy. Although the patient was not coma as 
was expected according to the strict defi nition of a cerebral 
malaria, the presence of Plasmodium falciparum with 
neurological symptoms, makes the diagnosis most likely. 
All patients with P. falciparum malaria with neurological 
manifestations of any degree should be treated as cases of 
cerebral malaria.1
There are sporadic case reports on cerebral malaria 
associated with focal neurological defi cits as presenting 
symptoms. Leopoldino et al2 reported a case of cerebral 
malaria presented with left hemiparesis in 1999. However, 
the imaging studies revealed fi ndings consistent with an 
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ischaemic stroke with persistent defi cits after complete 
eradication. Currie et al3 also reported 2 patients with 
focal neurological defi cit at presentation, which was later 
found to be due to pre-existing neurological disease prior 
to contracting malaria. However in our patient there were 
no signs and symptoms of any preexisting neurological 
disease. Idro et al4 and Sattar et al5 have documented cases 
of focal neurological defi cits with cerebral malaria without 
pre-existing neurological diseases. This suggests that there 
may be a separate mechanism which causes the neurological 
damage seen in cerebral malaria.
As the parasite stays only in the blood vessels, the question 
of how the infection causes neuronal dysfunction needs to 
be considered. Blood brain barrier dysfunction has been 
proposed to explain the observed phenomenon. Adam et 
al6 in 2002, suggested that binding of infected erythrocyte 
to Inter-Cellular Adhesion Molecule 1 (ICAM-1) on the 
cerebrovascular endothelium induces complex intracellular 
signaling cascade events, which affect the cytoskeletal-cell 
junction, causing alterations in the blood brain barrier. 
Localised increase in blood brain barrier permeability may 
cause localised increase in cytokines and infl ammatory 
mediators that may disrupt neuronal function and predispose 
a patient to neurological defi cit and seizures.6-8 
The presence of expressive dysphasia and left cerebellar 
signs imply the involvement of the Broca’s area and the 
left cerebellar hemisphere respectively. Simultaneous 
involvement of these 2 very distant intracranial sites are 
obviously a result of occlusion of 2 different vessels and 
activation of infl ammatory process at 2 distinct sites. The 
pathological process may be postulated to be occlusions of 
small vessels feeding these areas by “rosette” of infected 
erythrocytes or their “sticky” schizon causing micro-
infl ammatory or localised infl ammation rather than an overt 
large infl ammatory area with oedema or infarct would will 
be evident in a brain imaging study. 
Recovery following anti-malarial therapy may indicate 
underlying ischaemia rather than established infarcts similar 
to the pathogenesis of transient ischaemic attacks (TIA). An 
alternative explanation is resolution of the infl ammation in 
the affected areas as the parasites are eradicated. The latter 
postulation is much more plausible as recovery occurred over 
a period of days. Ischaemia would have been more likely 
to progress to infarcts, resulting in established permanent 
neurological damage if not reversed within 24 hours. 
Conclusion 
This case depicts the importance of cerebral malaria as a 
differential diagnosis of a pyrexial patient with neurological 
defi cits in tropical countries. A simple blood fi lm for malaria 
parasites had initiated the proper therapy and spared the 
patient from possible morbidity and mortality. This case 
also illustrates the unique neurological manifestations of 
cerebral malaria, which improved with quinine therapy. 
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